The PD-1/PD-L1 interaction inhibits antitumor activity of cytotoxic lymphocytes (CTLs) (12), which contributes to multiple Suppressive effects, such as immune escape, tumor proliferation, invasion, angiogenesis, and epithelial-mesenchymal transition (EMT) (13). This evidence concerns the gene PDCD1 and neoplasm.